BUY RBL Bank Limited — Rajesh Palviya, Axis Securities
RBL Bank share price target & all analyst calls
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))22 Apr 2026via ET Now
Entry₹321.65Inferred
Stop loss₹215-33.16% risk
Exit₹33529 Apr 2026, 10:00 am
Follow Rajesh Palviya for new calls(27% target hit, 176 closed calls)Get alertsWatch RBLBANK for new buy/sell callsGet alerts
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
0 supporting1 neutral0 opposing
Supports the BUY call (0)
Nothing found in this tip’s window yet.
Neutral / worth noting (1)
Weighs against the BUY call (0)
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on RBL Bank
- SELL — Prakash Gaba21 Oct 2026 · Same day · target ₹362 · Target hit
- BUY — Siddharth Khemka, Motilal Oswal16 Oct 2026 · ~1 year · target ₹485 · Active
- BUY — Manas Jaiswal13 Oct 2026 · ~3 months · target ₹420 · Active
- BUY — ICICI Securities13 Oct 2026 · ~1 year · target ₹460 · Active
- BUY — Investec India13 Oct 2026 · ~1 year · target ₹440 · Active
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

